Role of phytocompounds as the potential anti-viral agent: an overview

被引:0
|
作者
Swati Sucharita Mohanty
Chita Ranjan Sahoo
Sudhir Kumar Paidesetty
Rabindra Nath Padhy
机构
[1] IMS & Sum Hospital,Department of Medical Oncology
[2] Siksha ‘O’ Anusandhan Deemed to Be University,Central Research Laboratory
[3] IMS & Sum Hospital,Department of Health Research, Ministry of Health & Family Welfare, Govt. of India
[4] Siksha ‘O’ Anusandhan Deemed to Be University,Department of Medicinal Chemistry, School of Pharmaceutical Science
[5] ICMR-Regional Medical Research Centre,undefined
[6] Siksha ‘O’ Anusandhan Deemed to Be University,undefined
关键词
Phytochemicals; Natural product; COVID-19; Antiviral; Viral infection disease; SAR studies;
D O I
暂无
中图分类号
学科分类号
摘要
Viral diseases are the most notorious infective agent(s) causing morbidity and mortality in every nook and corner for ages; viruses are active in host cells, and specific anti-virus medicines’ developments remain uncanny. In this century of the biological era, human viruses act predominantly as versatile spreaders. The infection of the present COVID-19 virus is up in the air; blithely, the integument of medicinal chemistry approaches, particularly bioactive derived phytocompounds could be helpful to control those human viruses, recognized in the last 100 years. Indeed, natural products are being used for various therapeutic purposes. The major bioactive phytocompounds are chemically containing coumarin, thiosulfonate, steroid, polysaccharide, tannin, lignin, proanthocyanidin, terpene, quinone, saponin, flavonoid, alkaloid, and polyphenol, that are documented for inhibitory action against several viral infections. Mostly, about 20–30% of plants from tropical or temperate regions are known to have some antiviral activity. This comprehensive analysis of bioactive-derived phytocompounds would represent a significant impact and might be helpful for antiviral research and the current state of viral treatments.
引用
收藏
页码:2311 / 2329
页数:18
相关论文
共 50 条
  • [11] A novel role for neutrophils in anti-viral immunity
    Wubben, Richard
    Stevenson, Nigel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 232 - 232
  • [12] METABOLISM OF ARILDONE, AN ANTI-VIRAL AGENT, IN LABORATORY-ANIMALS
    BENZIGER, DP
    FRITZ, AK
    CLEMANS, SD
    EDELSON, J
    DRUG METABOLISM AND DISPOSITION, 1981, 9 (05) : 424 - 427
  • [13] A novel approach to the synthesis of the purine anti-viral agent gancyclovir
    Sariri, R
    Khalili, G
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2003, 42 (03): : 651 - 654
  • [14] Anti-viral agents: potential utility in exacerbations of asthma
    Dhariwal, Jaideep
    Edwards, Michael R.
    Johnston, Sebastian L.
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (03) : 331 - 336
  • [15] SYNTHESIS OF AS-TRIAZINES AS POTENTIAL ANTI-VIRAL AGENTS
    DAVIDSON, MW
    BOYKIN, DW
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (05) : 737 - 739
  • [16] Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity
    Poh, Chek Meng
    Chan, Yi-Hao
    Ng, Lisa F. P.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [17] Sugar modified pseudouridines as potential anti-viral agents
    Nunnari, Joseph
    Sappy, Immaculate
    Bryant-Friedrich, Amanda
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [18] SYNTHESIS OF HBB ANALOGS WITH POTENTIAL ANTI-VIRAL ACTIVITY
    SAWLEWICZ, J
    SACZEWSKI, F
    ACTA POLONIAE PHARMACEUTICA, 1978, 35 (04): : 507 - 507
  • [19] ANTI-VIRAL DRUGS
    BARCLAY, WR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 238 (23): : 2531 - 2532
  • [20] The anti-viral role of nitric oxide in coxsackievirus myocarditis
    Zaragoza, C
    Ocampo, CJ
    Saura, M
    McMillan, A
    Lowenstein, CJ
    CIRCULATION, 1997, 96 (08) : 2753 - 2753